Evidence map›Paper›PMID 31163614›Full record

ArticleHigh-throughput2019

Development and Optimization of a Miniaturized Western Blot-Based Screening Platform to Identify Regulators of Post-Translational Modifications.

Florencia Villafañez, Vanesa Gottifredi, Gastón Soria

Abstract read
In one paragraph

Article in High-throughput, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Florencia VillafañezCentro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET, Córdoba X5000, Argentina. florenciavillafaez@yahoo.com.ar.
Vanesa GottifrediFundación Instituto Leloir_Instituto de Investigaciones Bioquímicas de Buenos Aires, CONICET, Buenos Aires C1405BWE, Argentina. vgottifredi@gmail.com.
Gastón SoriaCentro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET, Córdoba X5000, Argentina. gsoria29@gmail.com.ORCID 0000-0003-2177-5094

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas PICT Start-Up 2013-1553
6 · The paper itself

Abstract

Post-translational modifications (PTMs) are fundamental traits of protein functionality and their study has been addressed using several approaches over the past years. However, screening methods developed to detect regulators of PTMs imply many challenges and are usually based on expensive techniques. Herein, we described the development and optimization of a western blot-based platform for identification of regulators of a specific PTM-mono-ubiquitylation of proliferating cell nuclear antigen (PCNA). This cell-based method does not require specific equipment, apart from the basic western blot (WB) devices and minor accessories, which are accessible for most research labs. The modifications introduced to the classical WB protocol allow the performance of PTM analysis from a single well of a 96-well plate with minimal sample manipulation and low intra- and inter-plate variability, making this method ideal to screen arrayed compound libraries in a 96-well format. As such, our experimental pipeline provides the proof of concept to design small screenings of PTM regulators by improving the quantitative accuracy and throughput capacity of classical western blots.

Indexed as

post-translational modificationscreeningwestern blot

Identifiers

PMID31163614
PMCPMC6631403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.